Your search returned 23 results.

Results
	1.	Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications. [electronic resource] by Garrett, Joan T Arteaga, Carlos L Producer: 20110921 In: Cancer biology & therapy vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Will PI3K pathway inhibitors be effective as single agents in patients with cancer? [electronic resource] by Garrett, Joan T Chakrabarty, Anindita Arteaga, Carlos L Producer: 20120629 In: Oncotarget vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Genomic alterations of ERBB receptors in cancer: clinical implications. [electronic resource] by Mishra, Rosalin Hanker, Ariella B Garrett, Joan T Publication details: Oncotarget Dec 2017 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? [electronic resource] by Garrett, Joan T Chakrabarty, Anindita Arteaga, Carlos L Publication details: Oncotarget 08 2018 In: Oncotarget vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	HER3 signaling and targeted therapy in cancer. [electronic resource] by Mishra, Rosalin Patel, Hima Alanazi, Samar Yuan, Long Garrett, Joan T Publication details: Oncology reviews Jan 2018 In: Oncology reviews vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. [electronic resource] by Miller, Todd W Rexer, Brent N Garrett, Joan T Arteaga, Carlos L Producer: 20120625 In: Breast cancer research : BCR vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Dual blockade of HER2 in HER2-overexpressing tumor cells does not completely eliminate HER3 function. [electronic resource] by Garrett, Joan T Sutton, Cammie R Kuba, María Gabriela Cook, Rebecca S Arteaga, Carlos L Producer: 20130715 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Current Advances in the Treatment of BRAF-Mutant Melanoma. [electronic resource] by Patel, Hima Yacoub, Nour Mishra, Rosalin White, Aaron Long, Yuan Alanazi, Samar Garrett, Joan T Publication details: Cancers 02 2020 In: Cancers vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Activating HER3 mutations in breast cancer. [electronic resource] by Mishra, Rosalin Alanazi, Samar Yuan, Long Solomon, Thomas Thaker, Tarjani M Jura, Natalia Garrett, Joan T Publication details: Oncotarget Jun 2018 In: Oncotarget vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	An evaluation of the U.S. in-flight medical kit. [electronic resource] by DeJohn, Charles A Véronneau, Stephen J H Wolbrink, Alex M Larcher, Julie G Smith, David W Garrett, Joan S Producer: 20021104 In: Aviation, space, and environmental medicine vol. 73 Availability: No items available. Save to lists Add to cart (remove)
	11.	An evaluation of in-flight medical care in the U.S. [electronic resource] by DeJohn, Charles A Wolbrink, Alex M Véronneau, Stephen J H Larcher, Julie G Smith, David W Garrett, Joan S Producer: 20021122 In: Aviation, space, and environmental medicine vol. 73 Availability: No items available. Save to lists Add to cart (remove)
	12.	Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu. [electronic resource] by Garrett, Joan T Rawale, Sharad Allen, Stephanie D Phillips, Gary Forni, Guido Morris, John C Kaumaya, Pravin T P Producer: 20070712 In: Journal of immunology (Baltimore, Md. : 1950) vol. 178 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Utilization of Reactive Oxygen Species Targeted Therapy to Prolong the Efficacy of BRAF Inhibitors in Melanoma. [electronic resource] by Yuan, Long Mishra, Rosalin Patel, Hima Abdulsalam, Safnas Greis, Kenneth D Kadekaro, Ana Luisa Merino, Edward J Garrett, Joan T Publication details: Journal of Cancer 2018 In: Journal of Cancer vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo. [electronic resource] by Allen, Stephanie D Garrett, Joan T Rawale, Sharad V Jones, Audra L Phillips, Gary Forni, Guido Morris, John C Oshima, Robert G Kaumaya, Pravin T P Producer: 20070807 In: Journal of immunology (Baltimore, Md. : 1950) vol. 179 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Combination of antibody that inhibits ligand-independent HER3 dimerization and a p110α inhibitor potently blocks PI3K signaling and growth of HER2+ breast cancers. [electronic resource] by Garrett, Joan T Sutton, Cammie R Kurupi, Richard Bialucha, Carl Uli Ettenberg, Seth A Collins, Scott D Sheng, Qing Wallweber, Jerry Defazio-Eli, Lisa Arteaga, Carlos L Producer: 20131212 In: Cancer research vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Oxidative Cyclization-Induced Activation of a Phosphoinositide 3-Kinase Inhibitor for Enhanced Selectivity of Cancer Chemotherapeutics. [electronic resource] by Zhu, Haizhou Mishra, Rosalin Yuan, Long Abdul Salam, Safnas F Liu, Jing Gray, George Sterling, Alyssa D Wunderlich, Mark Landero-Figueroa, Julio Garrett, Joan T Merino, Edward J Producer: 20200922 In: ChemMedChem vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis. [electronic resource] by Cook, Rebecca S Garrett, Joan T Sánchez, Violeta Stanford, Jamie C Young, Christian Chakrabarty, Anindita Rinehart, Cammie Zhang, Yixian Wu, Yaming Greenberger, Lee Horak, Ivan D Arteaga, Carlos L Producer: 20110920 In: Cancer research vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. [electronic resource] by Garrett, Joan T Olivares, María Graciela Rinehart, Cammie Granja-Ingram, Nara D Sánchez, Violeta Chakrabarty, Anindita Dave, Bhuvanesh Cook, Rebecca S Pao, William McKinely, Eliot Manning, H C Chang, Jenny Arteaga, Carlos L Producer: 20110526 In: Proceedings of the National Academy of Sciences of the United States of America vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer. [electronic resource] by Schwarz, Luis J Fox, Emily M Balko, Justin M Garrett, Joan T Kuba, María Gabriela Estrada, Mónica Valeria González-Angulo, Ana María Mills, Gordon B Red-Brewer, Monica Mayer, Ingrid A Abramson, Vandana Rizzo, Monica Kelley, Mark C Meszoely, Ingrid M Arteaga, Carlos L Producer: 20150708 In: The Journal of clinical investigation vol. 124 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors. [electronic resource] by Kaumaya, Pravin T P Foy, Kevin Chu Garrett, Joan Rawale, Sharad V Vicari, Daniele Thurmond, Jennifer M Lamb, Tammy Mani, Aruna Kane, Yahaira Balint, Catherine R Chalupa, Donald Otterson, Gregory A Shapiro, Charles L Fowler, Jeffrey M Grever, Michael R Bekaii-Saab, Tanios S Carson, William E Producer: 20091117 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 23 results.